The goal of this observational study is * to better understand the dominant modes of transmission * to estimate the extent of transmission among contacts by determining the secondary infection rate for human-to-human transmission at an individual level and identifying factors associated with secondary infections. * to determine the proportion of asymptomatic or pauci-symptomatic infections. * to characterize the incubation period of mpox and the duration of infectiousness, including reproduction numbers. * to assess serological responses following confirmed infection.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Transmission chain
Timeframe: through study completion, average 4 weeks
Incubation Period
Timeframe: through study completion, an average 4 weeks
Serial Interval
Timeframe: through study completion, an average 4 weeks
Secondary Attack Rate (SAR)
Timeframe: through study completion, an average 4 weeks
Effective Reproduction Number (Re)
Timeframe: through study completion, an average of 2 years